-
Something wrong with this record ?
Synthesis of pH-sensitive amphotericin B-poly(ethylene glycol) conjugates and study of their controlled release in vitro
Sedlák M, Pravda M, Staud F, Kubicová L, Týcová K, Ventura K.
Language English Country Great Britain
- MeSH
- Amphotericin B chemical synthesis chemistry MeSH
- Financing, Organized MeSH
- Spectrometry, Mass, Electrospray Ionization MeSH
- Hydrolysis MeSH
- Hydrogen-Ion Concentration MeSH
- Blood MeSH
- Humans MeSH
- Mice MeSH
- Polyethylene Glycols chemical synthesis chemistry MeSH
- Spectrophotometry, Infrared MeSH
- Spectrophotometry, Ultraviolet MeSH
- In Vitro Techniques MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Mice MeSH
- Animals MeSH
New intravenous conjugates of amphotericin B (AMB) with poly(ethylene glycols) (PEG) (M=5000, 10,000, 20,000) have been synthesized and characterised. The intermediate PEGs possess a 1,4-disubstituted benzene ring with aldehyde group at the end of the chain. The benzene ring is connected with PEG at its 4-position (with respect to the aldehyde group) by various functional groups (ether, amide, ester). Reaction of terminal aldehyde group of the substituted PEGs with AMB gave conjugates containing a pH-sensitive imine linkage, which can be presumed to exhibit antimycotic effect at sites with lowered pH value. All types of the conjugates are relatively stable in phosphate buffer at physiological conditions of pH 7.4 (37 degrees C), less than 5 mol% AMB being split off from them within 24 h. For a model medium of afflicted tissue was used a phosphate buffer (pH 5.5, 37 degrees C), in which controlled release of AMB from the conjugates takes place. The imine linkage is split to give free AMB with half-lives of 2-45 min. The rate of acid catalysed hydrolysis depends upon substitution of the benzene ring; however, it does not depend on molecular weights of the PEGs used. The conjugates with ester linkage undergo enzymatic splitting in human blood plasma and/or blood serum at pH 7.4 (37 degrees C) with half-lives of 2-5 h depending on molecular weights of the PEGs used (M = 5000, 10,000, 20,000). At first, the splitting of ester linkage produces the relatively stable pro-drug, that is, 4-carboxybenzylideniminoamphotericin B, which is decomposed to AMB and 4-formylbenzoic acid in a goal-directed manner only at pH 7 (t1/2 = 2 min, pH 5.5, 37 degrees C). A goal-directed release of AMB is only achieved by acid catalysed hydrolysis of imine linkage, either from the polymeric conjugate or from the pro-drug released thereof. The LD50 values determined in vivo (mouse) are 20.7 mg/kg and 40.5 mg/kg for the conjugates with ester linkage (M = 10,000 and 5000, respectively), which means that they are ca. 6-11 times less toxic than free AMB.
Department of Organic Chemistry University of Pardubice Cs legií 565 532 10 Pardubice Czech Republic
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10001251
- 003
- CZ-PrNML
- 005
- 20111210155158.0
- 008
- 100120s2007 xxk e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Sedlák, Miloš, $d 1959- $7 ola2002159209
- 245 10
- $a Synthesis of pH-sensitive amphotericin B-poly(ethylene glycol) conjugates and study of their controlled release in vitro / $c Sedlák M, Pravda M, Staud F, Kubicová L, Týcová K, Ventura K.
- 314 __
- $a Department of Organic Chemistry, University of Pardubice, Cs. legií 565, 532 10 Pardubice, Czech Republic. milos.sedlak@upce.cz
- 520 9_
- $a New intravenous conjugates of amphotericin B (AMB) with poly(ethylene glycols) (PEG) (M=5000, 10,000, 20,000) have been synthesized and characterised. The intermediate PEGs possess a 1,4-disubstituted benzene ring with aldehyde group at the end of the chain. The benzene ring is connected with PEG at its 4-position (with respect to the aldehyde group) by various functional groups (ether, amide, ester). Reaction of terminal aldehyde group of the substituted PEGs with AMB gave conjugates containing a pH-sensitive imine linkage, which can be presumed to exhibit antimycotic effect at sites with lowered pH value. All types of the conjugates are relatively stable in phosphate buffer at physiological conditions of pH 7.4 (37 degrees C), less than 5 mol% AMB being split off from them within 24 h. For a model medium of afflicted tissue was used a phosphate buffer (pH 5.5, 37 degrees C), in which controlled release of AMB from the conjugates takes place. The imine linkage is split to give free AMB with half-lives of 2-45 min. The rate of acid catalysed hydrolysis depends upon substitution of the benzene ring; however, it does not depend on molecular weights of the PEGs used. The conjugates with ester linkage undergo enzymatic splitting in human blood plasma and/or blood serum at pH 7.4 (37 degrees C) with half-lives of 2-5 h depending on molecular weights of the PEGs used (M = 5000, 10,000, 20,000). At first, the splitting of ester linkage produces the relatively stable pro-drug, that is, 4-carboxybenzylideniminoamphotericin B, which is decomposed to AMB and 4-formylbenzoic acid in a goal-directed manner only at pH 7 (t1/2 = 2 min, pH 5.5, 37 degrees C). A goal-directed release of AMB is only achieved by acid catalysed hydrolysis of imine linkage, either from the polymeric conjugate or from the pro-drug released thereof. The LD50 values determined in vivo (mouse) are 20.7 mg/kg and 40.5 mg/kg for the conjugates with ester linkage (M = 10,000 and 5000, respectively), which means that they are ca. 6-11 times less toxic than free AMB.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a amfotericin B $x chemická syntéza $x chemie $7 D000666
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a krev $7 D001769
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a koncentrace vodíkových iontů $7 D006863
- 650 _2
- $a hydrolýza $7 D006868
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a polyethylenglykoly $x chemická syntéza $x chemie $7 D011092
- 650 _2
- $a hmotnostní spektrometrie s elektrosprejovou ionizací $7 D021241
- 650 _2
- $a spektrofotometrie infračervená $7 D013055
- 650 _2
- $a spektrofotometrie ultrafialová $7 D013056
- 650 _2
- $a techniky in vitro $7 D066298
- 700 1_
- $a Pravda, Martin. $7 _AN043408
- 700 1_
- $a Štaud, František, $d 1970- $7 stk2007393932
- 700 1_
- $a Kubicová, Lenka, $d 1964- $7 xx0105104
- 700 1_
- $a Týčová, Kateřina $7 xx0128867
- 700 1_
- $a Ventura, Karel, $d 1952- $7 _AN026096
- 773 0_
- $w MED00000769 $t Bioorganic & medicinal chemistry $g Roč. 15, č. 12 (2007), s. 4069-4076 $x 0968-0896
- 910 __
- $a ABA008 $b x $y 8
- 990 __
- $a 20090310084605 $b ABA008
- 991 __
- $a 20100425172135 $b ABA008
- 999 __
- $a ok $b bmc $g 707176 $s 569972
- BAS __
- $a 3
- BMC __
- $a 2007 $b 15 $c 12 $d 4069-4076 $i 0968-0896 $m Bioorganic & medicinal chemistry $x MED00000769 $n Bioorg Med Chem
- LZP __
- $a 2010-b1/ipme